Bao, Yining
Lu, Pengyi
Wang, Mengjie
Zhang, Xueli
Song, Aowei
Gu, Xiaoyun
Ma, Ting
Su, Shu
Wang, Lin
Shang, Xianwen
Zhu, Zhuoting
Zhai, Yuhang
He, Mingguang
Li, Zengbin
Liu, Hanting
Fairley, Christopher K.
Yang, Jiangcun
Zhang, Lei http://orcid.org/0000-0003-2343-084X
Funding for this research was provided by:
National Key R&D Program of China (2022YFC2505100, 2022YFC2505103)
Outstanding Young Scholars Support Program (3111500001)
Epidemiology modeling and risk assessment (20200344)
Xi’an Jiaotong University Young Scholar Support Grant (YX6J004)
Article History
Received: 20 August 2023
Accepted: 29 November 2023
First Online: 13 December 2023
Declarations
:
: Ethical approval for our study related to the Shaanxi, China, was obtained from the institutional review board of the People’s Hospital of Shaanxi Province (No:2020-R002). It was pre-registered at China National Medical Research Register and Chinese Clinical Trial Registry; the registration number is ChiCTR2200055983 and MR-61–21-011750, respectively. The UK Biobank was approved by the North West Research Ethics Committee (06/MRE08/65), and all participants signed an informed consent document.
: Not applicable.
: The authors declare no competing interests.